Earnings History Data for Tyme Technologies, Inc. (TYME) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Tyme Technologies, Inc.

Tyme Technologies, Inc. is a pharmaceutical company. The company is focused on creating medicines which specialize in the body's immune system to treat diseases. Tyme Technologies, Inc. is headquartered in New York.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-02-2022	PM	8:00 AM ET (Feb 11)	TYME	Tyme Technologies, Inc.	61.93	-0.03	0.00	-0.05	Tyme Technologies GAAP EPS of -$0.03 [2/11/2022 6:52 AM]	0.3349	-0.02 (-4.91%)	0.37	0.01 (3.63%)	0.29 - 3.00	560,480	1,080,000	4,347
Tyme Technologies GAAP EPS of -$0.03 [2/11/2022 6:52 AM] TYME Technologies, Inc. Provides Business Update and Announces Third Fiscal Quarter 2022 Financial and Operating Results [Feb-11-22 06:50AM]
08-11-2021	PM	8:00 AM ET (Nov 8)	TYME	Tyme Technologies, Inc.	173.93	-0.03	0.00	-0.05	Tyme Technologies reports Q2 results [11/8/2021 6:58 AM]	1.00	0.03 (3.33%)	0.98	0.01 (0.76%)	0.91 - 4.99	1,014,894	710,000	70,106
Tyme Technologies reports Q2 results [11/8/2021 6:58 AM] TYME Technologies, Inc. Provides Business Update and Announces Second Fiscal Quarter 2022 Financial and Operating Results [Nov-08-21 06:50AM]
10-08-2021	PM	8:00 AM ET (Aug 10)	TYME	Tyme Technologies, Inc.	196.32	-0.03	0.00	-0.06	Tyme Technologies reports Q1 results [8/10/2021 6:54 AM]	1.10	-0.05 (-4.35%)	1.15	0.0 (0.00%)	0.85 - 4.99	2,543,680	5,660,000	129,491
Tyme Technologies reports Q1 results [8/10/2021 6:54 AM] Tyme Technologies reduces quarterly cash burn following strategic review [8/10/2021 9:53 AM] TYME Technologies, Inc. Provides Business Update and Announces Fiscal First Quarter 2022 Financial and Operating Results [Aug-10-21 06:45AM]
10-06-2021	AH	4:05 PM ET (Jun 10)	TYME	Tyme Technologies, Inc.	267.57	-0.03	0.00	-0.04		1.49	-0.10 (-6.60%)	1.63	0.04 (2.52%)	0.85 - 4.99	7,062,849	4,350,000	605,522
Tyme Technologies reports FY results [6/10/2021 4:32 PM] Tyme Technologies rises on pipeline update [6/10/2021 5:03 PM] Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results [Jun-10-21 04:17PM]
04-02-2021	PM		TYME	Tyme Technologies, Inc.	237.00	-0.05	-0.06	0.00	Tyme Technologies reports FQ3 results [2/4/2021 8:14 AM]	2.28	-1.25 (-35.41%)	2.56	-0.97 (-27.48%)	0.85 - 4.99	59,510,625	29,430,006	11,801,524
Tyme Technologies reports FQ3 results [2/4/2021 8:14 AM] Tyme Technologies to raise $100M via share sale [2/4/2021 3:36 AM] Tyme stock nabs U.S. patent for treatment of COVID-19 infections [2/3/2021 8:41 AM] Tyme falls after equity offer as quarterly data indicate liquidity pressure [2/4/2021 12:31 PM] TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results [Feb-04-21 08:00AM] The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs [Feb-04-21 07:21AM] Why viral stocks are here to stay [Feb-04-21 07:15AM] TYME Announces $100 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules [Feb-04-21 01:22AM] Why Tyme Technologies Stock Is Crushing It Today [Feb-03-21 12:30PM] TYME Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections [Feb-03-21 08:00AM]
04-02-2021	PM		TYME	Tyme Technologies, Inc.	231.71	-0.05	-0.06	-0.05	Tyme Technologies reports FQ3 results [2/4/2021 8:14 AM]	3.53	1.71 (93.96%)	2.54	-0.98 (-27.90%)	0.85 - 4.99	253,167,602	29,430,006	8,116,879
Tyme Technologies reports FQ3 results [2/4/2021 8:14 AM] Tyme Technologies to raise $100M via share sale [2/4/2021 3:36 AM] Tyme stock nabs U.S. patent for treatment of COVID-19 infections [2/3/2021 8:41 AM] TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results [Feb-04-21 08:00AM] Why viral stocks are here to stay [Feb-04-21 07:15AM] TYME Announces $100 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules [Feb-04-21 01:22AM] Why Tyme Technologies Stock Is Crushing It Today [Feb-03-21 12:30PM] TYME Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections [Feb-03-21 08:00AM]
20-05-2020	AH	4:05 PM ET (May 20)	TYME	Tyme Technologies, Inc.	208.83	-0.04	-0.07	-0.10	Tyme Technologies EPS beats by $0.04 [5/20/2020 4:10 PM]	1.60	-0.04 (-2.44%)	1.71	0.07 (4.27%)	0.86 - 2.04	318,831	423,801	8,106